Cargando…

Correlative outcomes of maternal immunization against RSV in cotton rats

Maternal anti-respiratory syncytial virus (RSV) antibodies protect neonates from RSV disease throughout first weeks of life. Previous studies of maternal immunization in cotton rats showed that a single immunization during pregnancy of RSV-primed dams with virus-like particles (VLPs) assembled with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanco, Jorge C. G., Cullen, Lori M., Kamali, Arash, Sylla, Fatoumata Y. D., Chinmoun, Zenab, Boukhvalova, Marina S., Morrison, Trudy G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Novel Vaccines – Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766472/ https://www.ncbi.nlm.nih.gov/pubmed/36503354 http://dx.doi.org/10.1080/21645515.2022.2148499

Ejemplares similares

Evolution of protection after maternal immunization for respiratory syncytial virus in cotton rats
por: Blanco, Jorge C. G., et al.
Publicado: (2021)

Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
por: Blanco, Jorge C. G., et al.
Publicado: (2023)

Comparisons of Antibody Populations in Different Pre-Fusion F VLP-Immunized Cotton Rat Dams and Their Offspring
por: Cullen, Lori M., et al.
Publicado: (2020)

Estimating the burden of adult hospitalized RSV infection using local and state data - methodology
por: Balasubramani, G. K., et al.
Publicado: (2022)

Establishment of the 1st Chinese national standard for CA6 neutralizing antibody
por: Wang, Yiping, et al.
Publicado: (2023)

A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal
por: Chaudhary, Shipra, et al.
Publicado: (2023)

The applications of animal models in phage therapy: An update
por: Mehmood Khan, Fazal, et al.
Publicado: (2023)

Immunogenicity and safety of the non-typable Haemophilus influenzae–Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial
por: Galgani, Ilaria, et al.
Publicado: (2023)

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study
por: Huang, Xiaoyuan, et al.
Publicado: (2023)

Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial
por: López, Pio, et al.
Publicado: (2023)

Preclinical safety evaluation of a bivalent inactivated EV71-CA16 vaccine in mice immunized intradermally
por: Liao, Yun, et al.
Publicado: (2023)

Analysis and prediction of the incidence and prevalence trends of gonorrhea in China
por: Chen, Xueya, et al.
Publicado: (2023)

An open-label, Phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-life
por: Patel, Sanjay S., et al.
Publicado: (2023)

Advancements in the development of nucleic acid vaccines for syphilis prevention and control
por: Li, Sijia, et al.
Publicado: (2023)

Acceptability for the influenza virus vector COVID-19 vaccine for intranasal spray: A cross-sectional survey in Beijing, China
por: Ma, Yuan, et al.
Publicado: (2023)

Challenges in development of vaccines directed toward antimicrobial resistant bacterial species
por: Brazzoli, Michela, et al.
Publicado: (2023)

Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches
por: Absalon, Judith, et al.
Publicado: (2022)

Adenovirus vector-based vaccines as forefront approaches in fighting the battle against flaviviruses
por: Shoushtari, Mohammad, et al.
Publicado: (2022)

SARS-CoV-2 infection augments species- and age-specific predispositions in cotton rats
por: Boukhvalova, Marina S., et al.
Publicado: (2023)

The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV
por: Cullen, Lori M., et al.
Publicado: (2017)

Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein
por: Cullen, Lori McGinnes, et al.
Publicado: (2015)

Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
por: Blanco, Jorge C. G., et al.
Publicado: (2018)

Immune camouflage: Relevance to vaccines and human immunology
por: De Groot, Anne S, et al.
Publicado: (2014)

A strategic model for developing vaccines against neglected diseases: An example of industry collaboration for sustainable development
por: Berlanda Scorza, Francesco, et al.
Publicado: (2022)

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults
por: Green, C, et al.
Publicado: (2023)

Species-specific transcriptomic changes upon respiratory syncytial virus infection in cotton rats
por: Strickland, Britton A., et al.
Publicado: (2022)

Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine
por: Bartsch, Yannic C., et al.
Publicado: (2023)

Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial
por: Dunning, Andrew J., et al.
Publicado: (2016)

Antibody-Based Correlates of Protection against Cholera: Analysis of a Challenge Study of a Cholera-Naive Population
por: Haney, Douglas J., et al.
Publicado: (2017)

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation
por: Stobart, Christopher C., et al.
Publicado: (2016)

Comparison of Immune Responses to Different Versions of VLP Associated Stabilized RSV Pre-Fusion F Protein
por: Cullen, Lori M., et al.
Publicado: (2019)

Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator
por: Sow, Samba O., et al.
Publicado: (2017)

A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults
por: Russell, Kevin L., et al.
Publicado: (2022)

Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization
por: Maxfield, Lori F., et al.
Publicado: (2015)

HIV-1 genetic diversity a challenge for AIDS vaccine development: a retrospective bibliometric analysis
por: Rashid, Abdur, et al.
Publicado: (2022)

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants
por: Huang, Yunda, et al.
Publicado: (2021)

Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017
por: Heppe Montero, Marco, et al.
Publicado: (2021)

Disease burden in patients with severe hand, foot, and mouth disease in Jiangsu Province: a cross-sectional study
por: Han, Ying, et al.
Publicado: (2022)

Effect of aging on immunogenicity and efficacy of inactivated influenza vaccines in cotton rats Sigmodon hispidus
por: Boukhvalova, Marina S., et al.
Publicado: (2020)

Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods
por: Rhodes, Sophie J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5lbbr0vf7bhu3nioqn2s2t3ejd